Document is current
Any future updates will be listed below
-
Authors
Schaub, Theres
Janke, Daniel
Zickler, Daniel
Lange, Claudia
Girndt, Matthias
Schindler, Ralf
Dragun, Duska
Hegner, Björn
-
Funding
Funding for this research was provided by:
Seventh Framework Programme (HEALTH-F2-2009-241544)
Gambro Dialysatoren
Baxter Inc
Projekt DEAL
- License Information
-
More Information
Article History
Received: 11 June 2020
Accepted: 10 November 2020
First Online: 13 January 2021
Competing interests
: RS and DZ report grants from Gambro. MG reports grants from Baxter Inc during the conduct of this study. RS, DZ and BH have a licensed patent (US 2015/0110887 A1) “Permselective membrane for treating vascular calcification in chronic hemodialysis patients”. TS, DJ, CL, and DD have no competing interests as defined by Nature Research, or other interests that might be perceived to influence the results and/or discussion reported in this paper.
